These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 6182323

  • 1. Antiallergic properties of an orally effective agent, [[3-(1H-tetrazol-5-yl)-phenyl] amino] oxoacetic acid n-butyl ester.
    Agata M, Goto H, Tsuriya Y, Tachibana K, Kuroda T.
    Jpn J Pharmacol; 1982 Aug; 32(4):689-97. PubMed ID: 6182323
    [Abstract] [Full Text] [Related]

  • 2. [Anti-allergic effects of tazanolast [butyl 3'-(1H-tetrazol-5-yl) oxanilate, WP-833] metabolites].
    Hashimoto T, Edanami K, Naito A, Sano K, Fushimi H, Goto M.
    Nihon Yakurigaku Zasshi; 1990 Apr; 95(4):159-66. PubMed ID: 1695192
    [Abstract] [Full Text] [Related]

  • 3. Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 1st communication: effects on type I to type IV allergic reactions in animal models.
    Yanagihara Y, Abe T, Edanami K, Agata M, Kuroda T, Shida T.
    Arzneimittelforschung; 1988 Jan; 38(1):70-4. PubMed ID: 2966629
    [Abstract] [Full Text] [Related]

  • 4. Potent inhibitory activity of HSR-6071, a new antiallergic agent, on passive cutaneous anaphylaxis (PCA).
    Makino E, Ohashi T, Takahashi H, Kato H, Ito Y, Nagai H, Koda A, Azuma H.
    Jpn J Pharmacol; 1990 Jan; 52(1):87-94. PubMed ID: 1689783
    [Abstract] [Full Text] [Related]

  • 5. Antiallergic effects of 4-[2-oxo-3-(1H-tetrazol-5-yl)-2H-chromen-8-yloxy]-bu tyric acid.
    Kuriyama K, Hiyama Y, Ito K.
    Jpn J Pharmacol; 1989 Jun; 50(2):111-8. PubMed ID: 2475659
    [Abstract] [Full Text] [Related]

  • 6. Antiallergic action of 6-ethyl-3-(1h-tetrazol-5-YL) chromone (AA-344) on immediate hypersensitivity reaction in rats.
    Kuriki H, Saijo T, Maki Y, Kanno M.
    Jpn J Pharmacol; 1979 Jun; 29(3):385-97. PubMed ID: 43912
    [Abstract] [Full Text] [Related]

  • 7. Immunopharmacological studies on TBX, a new antiallergic drug (1). Inhibitory effects on passive cutaneous anaphylaxis in rats and guinea pigs.
    Yanagihara Y, Kasai H, Kawashima T, Shida T.
    Jpn J Pharmacol; 1988 Sep; 48(1):91-101. PubMed ID: 2462074
    [Abstract] [Full Text] [Related]

  • 8. Effect of butyl 3-(1H-tetrazol-5-Yl) oxanilate (MTB) on immunological or non-immunological histamine and SRS(-A) release from guinea-pig, monkey and human lung tissue.
    Hashimoto T, Kohno SW, Ohata K, Yanagihara Y, Shida T.
    Jpn J Pharmacol; 1987 Aug; 44(4):447-53. PubMed ID: 2446036
    [Abstract] [Full Text] [Related]

  • 9. [The pharmacological properties of a new anti-allergic agent, KP-136, in cutaneous models].
    Kuriyama K, Hiyama Y, Ito K, Ichikawa K, Kitada S, Yoshinaka I.
    Nihon Yakurigaku Zasshi; 1987 Apr; 89(4):213-24. PubMed ID: 2440785
    [Abstract] [Full Text] [Related]

  • 10. CR 2039, a new bis-(1H-tetrazol-5-yl)phenylbenzamide derivative with potential for the topical treatment of asthma.
    Revel L, Colombo S, Ferrari F, Folco G, Rovati LC, Makovec F.
    Eur J Pharmacol; 1992 Dec 08; 229(1):45-53. PubMed ID: 1282105
    [Abstract] [Full Text] [Related]

  • 11. Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 2nd communication: inhibitory effects on histamine release from rat mast cells and lung fragments.
    Yanagihara Y, Abe T, Kuroda T, Shida T.
    Arzneimittelforschung; 1988 Jan 08; 38(1):75-9. PubMed ID: 2452639
    [Abstract] [Full Text] [Related]

  • 12. Antiallergic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413).
    Fukuda T, Saito T, Tajima S, Shimohara K, Ito K.
    Arzneimittelforschung; 1984 Jan 08; 34(7):805-10. PubMed ID: 6208915
    [Abstract] [Full Text] [Related]

  • 13. 3-(1H-tetrazol-5-yl)-4(3H)-quinazolinone sodium salt (MDL 427): a new antiallergic agent.
    Peet NP, Baugh LE, Sunder S, Lewis JE, Matthews EH, Olberding EL, Shah DN.
    J Med Chem; 1986 Nov 08; 29(11):2403-9. PubMed ID: 2431144
    [Abstract] [Full Text] [Related]

  • 14. Antiallergic properties of SQ 13,847, an orally effective agent. I. Activity in vivo.
    Casey FB, Abboa-Offei BE, Marretta J.
    J Pharmacol Exp Ther; 1980 Jun 08; 213(3):432-6. PubMed ID: 7205610
    [Abstract] [Full Text] [Related]

  • 15. CI-922--a novel, potent antiallergic compound--II. Activity in animal models of allergy.
    Adolphson RL, Finkel MP, Robichaud LJ.
    Int J Immunopharmacol; 1987 Jun 08; 9(1):51-60. PubMed ID: 2438239
    [Abstract] [Full Text] [Related]

  • 16. Effects of quinotolast, a new orally active antiallergic drug, on experimental allergic models.
    Kobayashi K, Hiroi J, Kishi S, Sawase K, Hirayama Y, Chihara S, Imai T, Shigi Y, Shimomura K, Kohsaka M.
    Jpn J Pharmacol; 1993 Sep 08; 63(1):73-81. PubMed ID: 7505860
    [Abstract] [Full Text] [Related]

  • 17. Inhibitory effect of HSR-6071, a new anti-allergic agent, on experimental asthma in rats and guinea-pigs.
    Makino E, Ohashi T, Takahashi H, Kato H, Ito Y, Nagai H, Koda A, Azuma H.
    J Pharm Pharmacol; 1990 Apr 08; 42(4):236-41. PubMed ID: 1974289
    [Abstract] [Full Text] [Related]

  • 18. [Effect of KC-404 on allergic reactions types I-IV].
    Nishino K, Hara S, Irikura T.
    Nihon Yakurigaku Zasshi; 1984 Apr 08; 83(4):291-9. PubMed ID: 6235160
    [Abstract] [Full Text] [Related]

  • 19. Antiallergic and anti-inflammatory action of tioxamast in rats. I. Antiallergic activity in vivo and in vitro.
    Tarayre JP, Aliaga M, Barbara M, Tisseyre N, Caillol V, Delhon A, Bruniquel F, N'Guyen X, Puech L, Tisné-Versailles J.
    Int Arch Allergy Appl Immunol; 1990 Apr 08; 92(1):69-76. PubMed ID: 1700967
    [Abstract] [Full Text] [Related]

  • 20. Anti-allergic properties of ethyl-3-methoxyphenyl-4-thiazolyl-2-oxamate (F 1865).
    Tarayre JP, Lauressergues H, Fauran F.
    Arch Int Pharmacodyn Ther; 1982 Nov 08; 260(1):165-76. PubMed ID: 6187305
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.